The application of human tissue for drug discovery and development

Bibliography

• Brisson AR, Matsui D, Rieder MJ, translational research in pediatrics: tissue sampling and biobanking. Pediatrics 2012;129(1):153-62
   PubMed Web of Science ®Google Scholar
• Webb CP, Pass HI. Translation research: from accurate diagnosis to appropriate treatment. J Transl Med 2004;2:35
   PubMedGoogle Scholar
• Sauter G, Simon R, Hillan K. Tissue microarrays in drug discovery. Nat Rev Drug Discov 2003;2:962-72
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. There are many sources for this statement, for example: Early identification of refractory epilepsy. N Engl J Med 2000; 342:314-19
   Google Scholar
• De Tisi J, Bell GS, Peacock JL, The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 2011;378(9800):1388-95
   PubMed Web of Science ®Google Scholar
• Roopun AK, Simonotto JD, Pierce ML, A nonsynaptic mechanism underlying interictal discharges in human epileptic neocortex. PNAS 2010;107(1):338-43
   PubMed Web of Science ®Google Scholar
• Cabrera O, Berman DM, Kenyon NS, The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci 2006;103(7):2334-9
   PubMed Web of Science ®Google Scholar
• Otonkoski T, Banerjee M, Korsgren O, Unique basement membrane structure of human pancreatic islets: implications for beta-cell growth and differentiation. Diabetes Obes Metab 2008;10(Suppl 4):119-27
   PubMedGoogle Scholar
• Bosco D, Armanet M, Morel P, Unique arrangement of alpha- and beta-cells in human islets of langerhans. Diabetes 2010;59(5):1202-10
   PubMed Web of Science ®Google Scholar
• Dougall IG. The use of human tissue in drug discovery. Cell Tissue Bank 2011;12(1):7-8
   PubMed Web of Science ®Google Scholar
• FDA. Guidance for Industry, Drug-Induced Liver Injury: Premarketing Clinical Evaluation, 2009
   Google Scholar
• Raucy JL, Mueller L, Duan K, Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. J Pharmacol Exp Ther 2002;302(2):475-82
   PubMed Web of Science ®Google Scholar
• Wilkening S, Stahl F, Bader A. Comparison of primary human hepatocytes and hepatoma cellline Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 2003;31:1035-42
   PubMed Web of Science ®Google Scholar
• BeruBe KA, Prytherch Z, Hughes T, Human primary bronchial lung cell constructs: the new respiratory models. Toxicology 2010;278:311-18
   PubMed Web of Science ®Google Scholar
• Huh D, Matthews BD, Mammoto A, Reconstituting organ-level lung functions on a chip. Science 2010;328:1662-8
   PubMed Web of Science ®Google Scholar
• Kim HJ, Huh D, Hamilton G, Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 2012; [Epub ahead of print]
   Web of Science ®Google Scholar
• Esch MB, King TL, Shuler ML. The role of body-on-a-chip devices in drug and toxicity studies. Annu Rev Biomed Eng 2011;13:55-72
   PubMed Web of Science ®Google Scholar
• Meer AD, Berg AV. Organs-on-chips: breaking the in vitro impasse. Integr Biol (Camb) 2012; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Sung JH, Shuler ML. Microtechnology for mimicking in vivo tissue environment. Ann Biomed Eng 2012; [Epub ahead of print]
   Web of Science ®Google Scholar
• Stebbings R, Findlay L, Edwards C, “Cytokine storm” in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol 2007;179(5):3325-31
   PubMed Web of Science ®Google Scholar
• Romer PS, Berr S, Avota E, Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood 2011;118(26):6772-82
   PubMed Web of Science ®Google Scholar
• Voisard R, Krugers T, Reinhardt B, HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasia. BMC Microbiol 2007;7:68
   Google Scholar
• Grivel JC, Santoro F, Chen S, Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J Virol 2003;77(15):8280-9
   PubMed Web of Science ®Google Scholar
• Vaira V, Fedele G, Pyne S, Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. PNAS 2010;107(18):8352-6
   PubMed Web of Science ®Google Scholar
• Sanger GJ. The way of all flesh. Public Service Review: UK Science and Technology, Issue 3, 17th October 2011
   Google Scholar
• Glukhov AV, Flagg TP, Fedorov VV, Differential KATP channel pharmacology in intact mouse heart. J Molecul Cell Cardiol 2010;48(1):152
   PubMed Web of Science ®Google Scholar
• Fedorov VV, Glukhov AV, Ambrosi CM, Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol 2011;51(2):215
   PubMed Web of Science ®Google Scholar
• US FDA. Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use. U. S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. February 28, 1997
   Google Scholar
• Tian Q, Price ND, Hood L. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med 2012;271(2):111-21
   PubMed Web of Science ®Google Scholar
• Foster CS, Dodson AR, Ambroisine L, Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer 2009;101:1137-44
   PubMed Web of Science ®Google Scholar
• Yao S, Bee A, Brewer D, PRKC-f Expression promotes the aggressive phenotype of human prostate cancer cells and is a novel target for therapeutic intervention. Genes Cancer 2010;1:444-64
   PubMedGoogle Scholar
• Barber RD, Harmer DW, Coleman RA, GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics 2005;21:389-95
   PubMed Web of Science ®Google Scholar
• Riegman PH, Morente MM, Betsou F, Biobanking for better healthcare. Mol Oncol 2008;2(3):213-22
   PubMed Web of Science ®Google Scholar
• Jweied E, deTombe P, Buttrick PM. The use of human cardiac tissue in biophysical research: the risks of translation. J Mol Cell Cardiol 2007;42(4):722-6
   Google Scholar
• Barnes RO, Parisien M, Murphy LC, Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev 2008;17:3344
   PubMed Web of Science ®Google Scholar
• Grizzle WE, Bell WC, Sexton KC. Issues in collecting, processing and storing human tissues and associated information to support biomedical research. Cancer Biomark 2011;9(1-6):531-49
   Web of Science ®Google Scholar
• Hartung T. A toxicology for the 21st Century—mapping the road ahead. Toxicol Sci 2009;109(1):18-23
   PubMed Web of Science ®Google Scholar
• Hartung T. Evidence-based toxicology – the toolbox of validation for the 21st Century? ALTEX 2010;27(4):253-63
   PubMedGoogle Scholar
• Hartung T. Food for Thought … on Validation. ALTEX 2007;24(2):67-80
   PubMed Web of Science ®Google Scholar
• Brennan FR, Morton LD, Spindeldreher S, Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies. MAbs 2010;2(3):233-55
   PubMed Web of Science ®Google Scholar
• European Medicines Agency Workshop. In vitro Cytokine release assays, London, September 2009. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2009/11/event_detail_000021.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c3&jsenabled=true [Last accessed 23 April 2012]
   Google Scholar
• Gunaseeli I, Doss MX, Antzelevitch C, Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. Curr Med Chem 2010;17(8):759-66
   PubMed Web of Science ®Google Scholar
• US FDA. Innovation or Stagnation, Challenge and Opportunity on the Critical Path to New Medical Products, 2004
   Google Scholar
• Herper M. The truly staggering cost of inventing new drugs. Forbes. 10th February 2012
   Google Scholar
• Coleman RA. Human tissue in the evaluation of safety and efficacy of new medicines: a viable alternative to animal models? ISRN Pharm 2011;2011:806789
   PubMedGoogle Scholar